CAS 1373422-53-7|GSK-J1
Introduction：Basic information about CAS 1373422-53-7|GSK-J1, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | GSK-J1 | ||
|---|---|---|---|
| CAS Number | 1373422-53-7 | Molecular Weight | 389.450 |
| Density | 1.3±0.1 g/cm3 | Boiling Point | 608.9±55.0 °C at 760 mmHg |
| Molecular Formula | C22H23N5O2 | Melting Point | / |
| MSDS | USA | Flash Point | 322.0±31.5 °C |
Names
| Name | N-[2-(2-Pyridinyl)-6-(1,2,4,5-tetrahydro-3H-3-benzazepin-3-yl)-4- pyrimidinyl]-β-alanine |
|---|---|
| Synonym | More Synonyms |
GSK-J1 BiologicalActivity
| Description | GSK-J1 is a potent inhibitor of H3K27me3/me2-demethylases JMJD3/KDM6B and UTX/KDM6A, with IC50 of 60 nM towards KDM6B. |
|---|---|
| Related Catalog | Signaling Pathways >>Epigenetics >>Histone DemethylaseResearch Areas >>Cancer |
| Target | IC50: 60 nM (KDM6B)[2] |
| In Vitro | GSK-J1 is selective for H3K27 demethylases of the KDM6 subfamily and specifically binds to endogenous JMJD3. GSK-J1 inhibits TNF-α production by human primary macrophages in an H3K27-dependent manner[1]. GSK-J1 inhibits the demethylase activity of KDM5C with 8.5-fold increased potency compared with that of KDM5B at 1 mM α-ketoglutarate, with IC50 of 11 μM and 94 μM, respectively[3]. |
| Kinase Assay | Purified JmjD3 (1 μM) and UTX (3 μM) is incubated with 10 μM peptide [BiotinKAPRKQLATKAARK(me3 )SAPATGG] in 50 mM HEPES pH 7.5, 150 mM KCl, 50 μM (NH4)2SO4·FeSO4·H2O, 1 mM 2-oxoglutarate, and 2 mM ascorbate (JmjD3, 3 minutes at 25°C; UTX, 20 minutes at 25°C) with various concentration of the inhibitor (0, 0.005, 0.01, 0.02, 0.05, 0.1 μM). 10 mM EDTA is added to stop the reaction. The reaction is desalted by zip tip and spotted on a MALDI plate with α-cyano-4-hydroxycinnamic acid MALDI matrix. Samples are analysed on a MALDI-TOF R system. |
| References | [1]. Kruidenier L, et al. A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response. Nature. 2012 Aug 16;488(7411):404-8. [2]. Heinemann B, et al. Inhibition of demethylases by GSK-J1/J4. Nature. 2014 Oct 2;514(7520):E1-2. [3]. Horton JR, et al. Characterization of a Linked Jumonji Domain of the KDM5/JARID1 Family of Histone H3 Lysine 4 Demethylases. J Biol Chem. 2016 Feb 5;291(6):2631-46. |
Chemical & Physical Properties
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 608.9±55.0 °C at 760 mmHg |
| Molecular Formula | C22H23N5O2 |
| Molecular Weight | 389.450 |
| Flash Point | 322.0±31.5 °C |
| Exact Mass | 389.185181 |
| PSA | 91.24000 |
| LogP | 2.75 |
| Vapour Pressure | 0.0±1.8 mmHg at 25°C |
| Index of Refraction | 1.653 |
| InChIKey | AVZCPICCWKMZDT-UHFFFAOYSA-N |
| SMILES | O=C(O)CCNc1cc(N2CCc3ccccc3CC2)nc(-c2ccccn2)n1 |
| Storage condition | -20℃ |
Safety Information
| RIDADR | NONH for all modes of transport |
|---|
Articles1
More Articles| Histone demethylase Utx regulates differentiation and mineralization in osteoblasts. J. Cell. Biochem. 116 , 2628-36, (2015) Alteration of methylation status of lysine 27 on histone H3 (H3K27) associates with dramatic changes in gene expression in response to various differentiation signals. Demethylation of H3K27 is contro... |
Synonyms
| β-Alanine, N-[2-(2-pyridinyl)-6-(1,2,4,5-tetrahydro-3H-3-benzazepin-3-yl)-4-pyrimidinyl]- |
| N-[2-(2-Pyridinyl)-6-(1,2,4,5-tetrahydro-3H-3-benzazepin-3-yl)-4-pyrimidinyl]-β-alanine |
| N-[2-(2-methyl-1H-indol-3-yl)ethyl]-4-pyridinecarboxamide |
| GSK-J1 |
